220 related articles for article (PubMed ID: 22538159)
1. Clinical requirements for closed-loop control systems.
Clarke WL; Renard E
J Diabetes Sci Technol; 2012 Mar; 6(2):444-52. PubMed ID: 22538159
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
3. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
[No Abstract] [Full Text] [Related]
4. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
Biagi L; Hirata Bertachi A; Conget I; Quirós C; Giménez M; Ampudia-Blasco FJ; Rossetti P; Bondia J; Vehí J
J Diabetes Sci Technol; 2017 Nov; 11(6):1089-1095. PubMed ID: 28633537
[TBL] [Abstract][Full Text] [Related]
5. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
6. A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2017 Nov; 11(6):1277. PubMed ID: 28879783
[No Abstract] [Full Text] [Related]
7. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
8. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.
Campos-Náñez E; Fortwaengler K; Breton MD
J Diabetes Sci Technol; 2017 Nov; 11(6):1187-1195. PubMed ID: 28569076
[TBL] [Abstract][Full Text] [Related]
10. Automatic data processing to achieve a safe telemedical artificial pancreas.
Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.
Tauschmann M; Thabit H; Leelarathna L; Elleri D; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2015 Oct; 9(6):1346-7. PubMed ID: 26451010
[No Abstract] [Full Text] [Related]
12. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
Klonoff DC; Kerr D
J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
[No Abstract] [Full Text] [Related]
13. Glycemic Tracking Before and After Insulin Pump Initiation.
Johnson A; Hill NE; Godsland I; Oliver NS
J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
[No Abstract] [Full Text] [Related]
14. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
15. Control to range for diabetes: functionality and modular architecture.
Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
[TBL] [Abstract][Full Text] [Related]
16. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
Thabit H; Leelarathna L; Wilinska ME; Elleri D; Allen JM; Lubina-Solomon A; Walkinshaw E; Stadler M; Choudhary P; Mader JK; Dellweg S; Benesch C; Pieber TR; Arnolds S; Heller SR; Amiel SA; Dunger D; Evans ML; Hovorka R
Diabetes Technol Ther; 2015 Nov; 17(11):801-7. PubMed ID: 26241693
[TBL] [Abstract][Full Text] [Related]
18. Real-world outcomes with different technology modalities in type 1 diabetes.
Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
[TBL] [Abstract][Full Text] [Related]
19. From Multiple Daily Injections to Hybrid Closed-Loop System in Ten Days, Utilizing a Structured Initiation Protocol.
Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
J Diabetes Sci Technol; 2020 May; 14(3):689-690. PubMed ID: 31876178
[No Abstract] [Full Text] [Related]
20. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
